ProCE Banner Activity

Individualizing Treatment for Patients With RA, axSpA, and PsA: Considerations and Strategies

Clinical Thought

This expert commentary offers a review of the key considerations for managing patients with rheumatoid arthritis, axial spondyloarthritis, or psoriatic arthritis using the latest guideline recommendations.

In Collaboration With the Society of Physician Assistants in Rheumatology

SPAR Logo

Released: September 14, 2022

Expiration: September 13, 2023

Share

Faculty

Jennifer L. Simpson

Jennifer L. Simpson, DNP

Adult-Gerontology Doctor of Nursing Practice
Arizona Arthritis and Rheumatology Associates
Glendale, Arizona

Acknowledgement

This activity is supported by educational grants from Amgen; and Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Supporters

Amgen

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Target Audience

NPs and PAs in rheumatology and primary care

Disclosure

Jennifer Simpson, DNP: consultant/advisor/speaker: AbbVie, Amgen, AstraZeneca, Horizon, Janssen.

Format

ClinicalThought Commentary

Additional Information

Program Medium

This program has been made available online.